These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone. Mouridsen HT, Palshof T. Prog Clin Biol Res; 1977 Mar; 12():459-66. PubMed ID: 335404 [No Abstract] [Full Text] [Related]
3. Combination chemotherapy for disseminated carcinoma of the breast. Lozada JA, Grillo-López A, Vélez-Garciá E. Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588 [No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S. Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501 [Abstract] [Full Text] [Related]
6. Combination chemotherapy in the treatment of advanced breast cancer. Rosner D, Nemoto T, Dao TL. J Surg Oncol; 1976 Jan 01; 8(6):465-9. PubMed ID: 994508 [Abstract] [Full Text] [Related]
9. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program. Muss HB, White DR, Cooper MR, Richards F, Spurr CL. Arch Intern Med; 1977 Dec 01; 137(12):1711-4. PubMed ID: 337916 [Abstract] [Full Text] [Related]
11. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project. Smalley RV, Carpenter J, Bartolucci A, Vogel C, Krauss S. Cancer; 1977 Aug 01; 40(2):625-32. PubMed ID: 329975 [Abstract] [Full Text] [Related]
12. CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study. Kolarić K, Roth A, Vukas D, Cervek J. Cancer Chemother Pharmacol; 1984 Aug 01; 13(2):142-4. PubMed ID: 6380789 [Abstract] [Full Text] [Related]
13. [Iatrogenic diabetic coma. Contribution to adverse effects of cytostatic therapy]. Barb U, Vielberg H. Strahlentherapie; 1973 Feb 01; 145(2):234-7. PubMed ID: 4694661 [No Abstract] [Full Text] [Related]
14. Five-drug therapy in advanced breast cancer: factors influencing toxicity and response. Davis HL, Ramirez G, Ellerby RA, Ansfield FJ. Cancer; 1974 Aug 01; 34(2):239-45. PubMed ID: 4852055 [No Abstract] [Full Text] [Related]
15. Combination chemotherapy in disseminated carcinoma of the breast. Stutz FH, Blom J, Tormey DC. Oncology; 1974 Aug 01; 29(2):139-46. PubMed ID: 4525917 [No Abstract] [Full Text] [Related]
16. Chemotherapy of breast carcinoma. Shingleton WW, Sedransk N, Johnson RO. Oncology; 1972 Aug 01; 26(2):287-96. PubMed ID: 5049923 [No Abstract] [Full Text] [Related]
19. Nonbacterial pneumonitis with multidrug antineoplastic therapy in breast carcinoma. Stutz FH, Tormey DC, Blom J. Can Med Assoc J; 1973 Mar 17; 108(6):710-4. PubMed ID: 4691105 [Abstract] [Full Text] [Related]
20. [Treatment of advanced breast cancer with a combination of vincristine, fluorouracil, methotrexate, cyclophosphamide and prednisone]. Rosso R, Brema F, Santi L. Tumori; 1973 Mar 17; 59(2):163-5. PubMed ID: 4720643 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]